GSK plc Diluted Earnings Loss Per Share
GSK plc (GSK) reported Diluted Earnings Loss Per Share of 1.388 GBP/shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShare · last filed 2026-03-06
| Period end | Diluted Earnings Loss Per Share 12 month | Diluted Earnings Loss Per Share 12 month as first filed |
|---|---|---|
| 2025-12-31 | 1.39 GBP/shares 20-F · filed 2026-03-06 | |
| 2024-12-31 | 0.62 GBP/shares 20-F · filed 2026-03-06 | |
| 2023-12-31 | 1.20 GBP/shares 20-F · filed 2026-03-06 | |
| 2022-12-31 | 3.66 GBP/shares 20-F · filed 2025-03-03 | |
| 2021-12-31 | 1.08 GBP/shares 20-F · filed 2024-03-05 | 0.87 GBP/shares 20-F · filed 2022-03-08 |
| 2020-12-31 | 1.43 GBP/shares 20-F · filed 2023-03-10 | 1.14 GBP/shares 20-F · filed 2021-03-12 |
| 2019-12-31 | 0.93 GBP/shares 20-F · filed 2022-03-08 | |
| 2018-12-31 | 0.73 GBP/shares 20-F · filed 2021-03-12 | |
| 2017-12-31 | 0.31 GBP/shares 20-F · filed 2020-03-06 | |
| 2016-12-31 | 0.19 GBP/shares 20-F · filed 2019-03-15 | |
| 2015-12-31 | 1.72 GBP/shares 20-F/A · filed 2018-03-20 |